Apollon Formularies Plc: Apollon Formularies- CEO Review of 2021

LONDON, Jan. 25, 2022 /PRNewswire/ -- Apollon Formularies plc (AQSE: APOL) , ("Apollon" or the "Company"), a UK based international pharmaceutical company specializing in medical cannabis and

Related Keywords

United States ,University Of The West Indies ,Saint Andrew ,Jamaica ,United Kingdom ,Texas ,Houston ,University Of Texas ,London ,City Of ,Negril ,Westmoreland ,America ,Jamaican ,American ,Stephend Barnhill ,Herb Fritsche ,Anthony Hall ,Archibald Mcdonald ,Al Dawes ,Marjorie Vassell ,Stephen Barnhill Jr ,Stene Jacobs ,Jodi Anne Mckenley King ,Dingle Spence ,Cannabis License Authority ,Faculty Of Medical Sciences ,National Cancer Institute ,Jazz Pharmaceuticals ,Ministry Of Health ,Md Anderson Cancer Center ,Institute Is Dr ,Apollon International Cancer ,Gw Pharmaceuticals ,Expert Panel ,Arena Pharmaceuticals ,Chronic Pain Institute ,Apollon Formularies Jamaica Ltd ,Mcdonald ,Public Service ,Bloomberg ,International Cancer ,Apollon Formularies Inc ,Wellness Ethics Panel ,Drug Administration ,Head Of Corporate Development ,Professor Of Laboratory Medicine ,University Dean ,Our Research ,Chief Executive Officer ,Fellow Shareholders ,Apollon Formularies ,Big Pharma ,Medical Cannabis With ,Global Opportunity Analysis ,Industry Forecast ,Pre Clinical Cancer Testing ,Apollon Cancer Formulations ,Chief Science Officer ,Clinical Chemist ,Laboratory Medicine ,Clinical Chemistry Section ,Cancer Center ,Tumor Marker Practice Guidelines ,American Society ,Clinical Oncology ,Laboratory Practice Guidelines Committee ,National Academy ,Clinical Biochemistry ,Editorial Board ,Chronic Pain ,Medical Director ,Radiation Therapy ,Palliative Care ,Honorable Archibald Mcdonald ,Professor Emeritus ,Former University Dean ,Medical Sciences ,Pro Vice Chancellor ,West Indies ,Current Chairman ,Wellness Ethics ,Production Upgrade ,License Authority ,Stephen Barnhill ,Chief Operating ,North America ,Apollon Formularies Jamaica ,Corporate Development ,Rod Mcillree ,Napollon ,Formularies ,Review ,021 ,